These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7538043)

  • 1. How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma.
    Brawer MK
    CA Cancer J Clin; 1995; 45(3):148-64. PubMed ID: 7538043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.
    Roberts RO; Bergstralh EJ; Lieber MM; Jacobsen SJ
    Urology; 2000 Nov; 56(5):817-22. PubMed ID: 11068309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening in prostate carcinoma].
    Wirth MP; Spiegel T; Froschermaier SE; Manseck A
    Z Arztl Fortbild Qualitatssich; 1998 Jun; 92(5):304-9. PubMed ID: 9702818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
    Catalona WJ; Smith DS; Ornstein DK
    JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.
    Rietbergen JB; Kranse R; Kirkels WJ; De Koning HJ; Schröder FH
    Br J Urol; 1997 Apr; 79 Suppl 2():57-63. PubMed ID: 9126071
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on urology--prostate cancer. Screening for prostate cancer: an European view.
    de Silva FC
    Eur J Surg Oncol; 1996 Apr; 22(2):189-91, 196. PubMed ID: 8608840
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.
    Ross KS; Carter HB; Pearson JD; Guess HA
    JAMA; 2000 Sep; 284(11):1399-405. PubMed ID: 10989402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study.
    Bretton PR
    South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An analysis of preliminary results in screening for prostatic cancer].
    Matveev BP; Bukharkin BV; Komarova LE; Kadagidze ZG; Sholokhov VN; Sokolov AV; Smirnov AV; Cheban NL; Perederiĭ NV; Lepédatu PI
    Urol Nefrol (Mosk); 1998; (2):30-4. PubMed ID: 9577701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and early detection for prostate cancer.
    Magoha GA
    East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening: the need for problem-solving that puts men's interests first.
    Holmberg L
    Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer.
    Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J
    J Urol; 1995 Sep; 154(3):1085-9. PubMed ID: 7543604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.
    Halpern JA; Oromendia C; Shoag JE; Mittal S; Cosiano MF; Ballman KV; Vickers AJ; Hu JC
    J Urol; 2018 Apr; 199(4):947-953. PubMed ID: 29061540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.